External quality monitoring facilitates improvement in already well-performing stroke units: insights from RES-Q Poland

Michał Karliński, Adam Kobayashi, Maciej Niewada, Waldemar Fryze, Agata Tomczak, Waldemar Brola, Konrad Rejdak, Piotr Luchowski, Bożena Adamkiewicz, Małgorzata Wiszniewska, Urszula Włodarczyk, Radosław Kaźmierski, Pawel Kram, Halina Bartosik-Psujek, Rafał Kaczorowski, Piotr Sobolewski, Małgorzata Fudala, Agata Gałązka, Marcin Rogoziewicz, Anna Rogoziewicz, Halina Sienkiewicz-Jarosz, Ewelina Cybulska, Natalia Pożarowszczyk, Jacek Staszewski, Aleksander Dębiec, Ewa Horoch-Łyszczarek, Alicja Mączkowiak, Anna Czlonkowska

Vol 58, No 1 (2024)

Research Paper

Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic

Adam Stępień, Aleksandra Pogoda-Wesołowska, Elżbieta Tokarz-Kupczyk, Agnieszka Słowik, Przemysław Puz, Monika Adamczyk-Sowa, Iwona Kurkowska-Jastrzębska, Alina Kułakowska, Monika Chorąży, Karolina Piasecka-Stryczyńska, Anna Jamróz-Wiśniewska, Helena Bartosik-Psujek, Konrad Rejdak

Vol 57, No 4 (2023)

Research Paper

Post-COVID ‘brain fog’ will clear up only through neuropsychological examination

Josef Finsterer, Sounira Mehri

Vol 57, No 3 (2023)

Letter to the Editors

Response to Letter to the Editors regarding article entitled ‘Sex-related patient-reported brain fog symptoms in nonhospitalised COVID-19 patients’

Żaneta Chatys-Bogacka, Iwona Mazurkiewicz, Joanna Słowik, Klaudia Nowak, Wojciech Sydor, Barbara Wizner, Agnieszka Słowik, Marcin Wnuk, Leszek Drabik

Vol 57, No 3 (2023)

Response to Letter to the Editors

Immune response to COVID-19 vaccines in patients with multiple sclerosis treated with disease-modifying therapies

Waldemar Brola

Vol 57, No 1 (2023)

Invited Editorial

Incidence of dystonia related to COVID-19 infection

Marita F. Thiel, Wolfgang H. Jost

Vol 57, No 1 (2023)

Letter to the Editors

Electrophysiological and neuroimaging tools to evaluate neurological symptoms, manifestations, and complications in patients with long COVID-19

Gustavo José Luvizutto, Rodrigo Bazan

Vol 57, No 1 (2023)

Invited Editorial

Sex-related patient-reported brain fog symptoms in non-hospitalised COVID-19 patients

Żaneta Chatys-Bogacka, Iwona Mazurkiewicz, Joanna Słowik, Klaudia Nowak, Wojciech Sydor, Barbara Wizner, Agnieszka Słowik, Marcin Wnuk, Leszek Drabik

Vol 57, No 1 (2023)

Research Paper

International study: Global impact of COVID-19 on stroke care — the Polish contribution

Anetta Lasek-Bal, Anna Członkowska, Muhammad M. Qureshi, Mohamad Abdalkader, Joao Pedro Marto, Patrik Michel, Hiroshi Yamagami, Robert Mikulik, Jelle Demeestere, Zhongming Qiu, Thanh N. Nguyen, Raul G. Nogueira

Vol 57, No 1 (2023)

Letter to the Editors

Impact of SARS-CoV-2 on the nervous system

Agata Czarnowska, Joanna Zajkowska, Alina Kułakowska

Vol 57, No 1 (2023)

Review Article

COVID-19 and autoimmune diseases of the nervous system — an update

Natalia Morawiec, Bożena Adamczyk, Monika Adamczyk-Sowa

Vol 57, No 1 (2023)

Review Article

Blood-brain barrier function in response to SARS-CoV-2 and its spike protein

Łukasz Suprewicz, Krzysztof Fiedoruk, Agata Czarnowska, Marcin Sadowski, Agnieszka Strzelecka, Peter A. Galie, Paul A. Janmey, Alina Kułakowska, Robert Bucki

Vol 57, No 1 (2023)

Review Article

Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians

Klara Dyczkowska, Alicja Kalinowska-Łyszczarz

Vol 57, No 1 (2023)

Review Article

Course of fatigue among patients previously hospitalised due to COVID-19

Iwona Mazurkiewicz, Żaneta Chatys-Bogacka, Joanna Słowik, Magdalena Zdanecka, Andżelika Siwiec-Koźlik, Agnieszka Słowik, Leszek Drabik, Marcin Wnuk

Vol 57, No 1 (2023)

Research Paper

COVID-19-related headache and innate immune response — a narrative review

Marcin Straburzyński, Ewa Kuca-Warnawin, Marta Waliszewska-Prosół

Vol 57, No 1 (2023)

Review Article